Katie Griffin - Concepedia

Concepedia

Author

Katie Griffin

John Jay College of Criminal Justice

Also Known As

Katie E. Griffin, Katie Griffin

23

Publications

1.3K

Citations

11

H-Index

37

Concepts

All Affiliations

John Jay College of Criminal Justice City University of New York Fred Hutch Cancer Center Yale University UC Davis Comprehensive Cancer Center

KG

About

Katie Griffin is an author at John Jay College of Criminal Justice specializing in medicine, mental health, and african american studies.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	192
2	African American Studies	4	4	963
3	Health Sciences	3	3	44
4	Social Sciences	3	3	925
5	Education	2	2	815

Katie Griffin

×

10

Publications

1.3K

Citations

10

H-Index

	Year	Citations
The Impact of Racial Microaggressions on Mental Health: Counseling Implications for Clients of Color Kevin L. Nadal, Katie Griffin, Yinglee Wong, Journal of Counseling & Development EthnicityDiscriminationCounseling ImplicationsRacial PrejudiceEducation	2014	493
The Adverse Impact of Racial Microaggressions on College Students’ Self-Esteem Kevin L. Nadal, Yinglee Wong, Katie Griffin, Journal of college student development DiscriminationRacial PrejudiceEducationMental HealthSocial Sciences	2014	322
Subtle and Overt Forms of Islamophobia: Microaggressions toward Muslim Americans Kevin L. Nadal, Katie Griffin, Sahran Hamit, Journal of Muslim Mental Health	2012	153
Racial microaggressions and Asian Americans: An exploratory study on within-group differences and mental health. Kevin L. Nadal, Yinglee Wong, Julie Sriken, Asian American Journal of Psychology EthnicityHealth DisparitiesMental HealthSocial Determinants Of HealthRacial Disparities	2014	110
The Injurious Relationship Between Racial Microaggressions and Physical Health: Implications for Social Work Kevin L. Nadal, Katie Griffin, Yinglee Wong, Journal of Ethnic & Cultural Diversity in Social Work	2016	90
Religious microaggressions in the United States: Mental health implications for religious minority groups. Kevin L. Nadal, Marie-Anne Issa, Katie Griffin, Mental Health ImplicationsPsychiatryReligion StudiesMedicineReligious Prejudice	2010	38
Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth Yu-Chung Lin, Katherine Keenan, Jiafen Gong, Genetics in Medicine	2021	26
Phase II study of the FGFR inhibitor AZD4547 in previously treated patients with FGF pathway-activated stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400D. Charu Aggarwal, Mary W. Redman, Primo N. Lara, Journal of Clinical Oncology Fgfr3 AmplificationAdvanced Lung DiseaseMedicineClinical TrialsPathology	2017	16
A phase II study of GDC-0032 (taselisib) for previously treated PI3K positive patients with stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400B. James L. Wade, Corey J. Langer, Mary W. Redman, Journal of Clinical Oncology Progressive SqnsclcMedicinePharmacologyPathologyPhase Ii Study	2017	15
A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub-study SWOG S1400C. Martin J. Edelman, Mary W. Redman, Kathy S. Albain, Journal of Clinical Oncology PathologyPhase Ii StudyCcnd2 AmplificationOncologyClinical Trials	2017	13

Page 1